Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Zou

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
JCO Clinical Cancer Informatics|March 27, 2026
Machine Learning Model for Predicting Severe Adverse Events in Oncology Patients Using the US Food and Drug Administration Adverse Event Reporting SystemLuke Xiyu Zhao, Catherine Wang, Jonathan Zou, et al.
JMIR Formative Research|September 19, 2024
Public Perceptions of the Food and Drug Administration's Regulatory Authority Over Synthetic Nicotine on Twitter: Observational StudyJonathan Zou, Juan Ramon Feliciano, Zidian Xie, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 2024
Early Adverse Respiratory Outcomes in Obese Pediatric Tonsillectomy PatientsKathryn Wie, Nicholas Zaccor, Jonathan Zou, et al.
Medical Oncology (Northwood, London, England)|November 30, 2024
The physician payments Sunshine Act and medical oncology: a seven-year financial analysisXiyu Zhao, Victor Yang, Mohammed Ullah, et al.
Journal of Medical Internet Research|July 15, 2022
Perceptions of Oral Nicotine Pouches on Reddit: Observational StudyYihan Shao, Jonathan Zou, Zidian Xie, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier diseaseShivam A Zaver, Mrinal K Sarkar, Shaun Egolf, et al.
Plos One|December 1, 2015
Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell ToleranceEmily Xie, Abhiroop Kotha, Tracy Biaco, et al.
JCI Insight|August 10, 2023
Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier diseaseShivam A Zaver, Mrinal K Sarkar, Shaun Egolf, et al.
Science Advances|December 10, 2021
MLL4 mediates differentiation and tumor suppression through ferroptosisShaun Egolf, Jonathan Zou, Amy Anderson, et al.
Nature Communications|January 22, 2026
Stress vesicles link epidermal mechanotransduction to stem cell differentiationSixia Huang, Paola Kuri, Jonathan Zou, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
JCO Clinical Cancer Informatics|March 27, 2026
Machine Learning Model for Predicting Severe Adverse Events in Oncology Patients Using the US Food and Drug Administration Adverse Event Reporting SystemLuke Xiyu Zhao, Catherine Wang, Jonathan Zou, et al.
JMIR Formative Research|September 19, 2024
Public Perceptions of the Food and Drug Administration's Regulatory Authority Over Synthetic Nicotine on Twitter: Observational StudyJonathan Zou, Juan Ramon Feliciano, Zidian Xie, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 2024
Early Adverse Respiratory Outcomes in Obese Pediatric Tonsillectomy PatientsKathryn Wie, Nicholas Zaccor, Jonathan Zou, et al.
Medical Oncology (Northwood, London, England)|November 30, 2024
The physician payments Sunshine Act and medical oncology: a seven-year financial analysisXiyu Zhao, Victor Yang, Mohammed Ullah, et al.
Journal of Medical Internet Research|July 15, 2022
Perceptions of Oral Nicotine Pouches on Reddit: Observational StudyYihan Shao, Jonathan Zou, Zidian Xie, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier diseaseShivam A Zaver, Mrinal K Sarkar, Shaun Egolf, et al.
Plos One|December 1, 2015
Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell ToleranceEmily Xie, Abhiroop Kotha, Tracy Biaco, et al.
JCI Insight|August 10, 2023
Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier diseaseShivam A Zaver, Mrinal K Sarkar, Shaun Egolf, et al.
Science Advances|December 10, 2021
MLL4 mediates differentiation and tumor suppression through ferroptosisShaun Egolf, Jonathan Zou, Amy Anderson, et al.
Nature Communications|January 22, 2026
Stress vesicles link epidermal mechanotransduction to stem cell differentiationSixia Huang, Paola Kuri, Jonathan Zou, et al.
Pageof 2